Primary tabs

Search
Limit to
Export 48 results:
Filters: Author is Marta Romano
2021
Early high antibody-titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma., Devos, Timothy, Van Thillo Quentin, Compernolle Veerle, Tomé Najdovski, Romano Marta, Dauby Nicolas, Jadot Laurent, Leys Mathias, Maillart Evelyne, Loof Sarah, et al. , Eur Respir J, 2021 Aug 26, (2021)
In-vivo expressed Mycobacterium tuberculosis antigens recognised in three mouse strains after infection and BCG vaccination., Coppola, Mariateresa , NPJ Vaccines, 2021 Jun 03, Volume 6, Issue 1, (2021)
Lentiviral vector induces high-quality memory T cells via dendritic cells transduction., Wen, Ku, Min, Authié Pierre, Nevo Fabien, and Bourgine Maryline , Commun Biol, 2021 Jun 10, Volume 4, Issue 1, (2021)
Recognition by Dendritic Cells Negatively Regulates Allergic Lung Inflammation through a TLR2/MyD88 Pathway., Percier, Pauline, De Prins Sofie, Romano Marta, and Denis Olivier , Am J Respir Cell Mol Biol, 2021 Jan, Volume 64, Issue 1, (2021)
SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data., Dung, Nguyen, Simmonds Peter, Steenhuis Maurice, Wouters Elise, Desmecht Daniel, Garigliany Mutien, Romano Marta, Barbezange Cyril, Maes Piet, Van Holm Bram, et al. , Euro Surveill, 2021 07, Volume 26, Issue 27, (2021)
2020
Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of valescent plasma to the standard of care in patients hospitalized with COVID- nCoV (DAWn-Plasma) trial., Devos, Timothy , Trials, 2020 Dec 14, Volume 21, Issue 1, (2020)
The global response to the COVID-19 pandemic: how have immunology societies contributed?, Osier, Faith , Nat Rev Immunol, 2020 Oct, Volume 20, Issue 10, (2020)
Progressive Control of Streptococcus agalactiae-Induced Innate Inflammatory Response Is Associated with Time Course Expression of MicroRNA-223 by Neutrophils., Deny, Maud, and Casimir Georges , Infect Immun, 2020 Nov 16, Volume 88, Issue 12, (2020)
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the DAWn-Plasma trial., Devos, Timothy, Geukens Tatjana, Schauwvlieghe Alexander, Ariën Kevin K., Barbezange Cyril, Cleeren Myriam, Compernolle Veerle, Dauby Nicolas, Desmecht Daniel, Grimaldi David, et al. , Trials, 2020 Nov 27, Volume 21, Issue 1, (2020)

QR code

QR code for this page URL